Billionaire Ken Griffin Sells Amazon Stock and Buys an AI Stock Up 1,030% Since 2024 (Hint: Not Nvidia)
The Motley Fool· 2025-12-26 16:55
Top hedge fund manager Ken Griffin sold Amazon and bought Palantir in the third quarter.Ken Griffin runs Citadel Advisors, the most successful hedge fund in history as measured by net gains since inception. Additionally, Citadel outperformed the S&P 500 (^GSPC +0.32%) by 8 percentage points over the last three years. That makes Griffin an excellent source of inspiration for retail investors.In the third quarter, Citadel sold 1.6 million shares of Amazon (AMZN +0.10%) and purchased 388,000 shares of Palantir ...
Meet the Little-Known Company Yielding Nearly 14% That Can Continue to Deliver Monthly for Income Seekers in 2026
The Motley Fool· 2025-12-26 16:51
This under-the-radar company is, arguably, the safest double-digit-yielding stock on Wall Street.Over the last century, no asset class has generated a higher average annual return than stocks. With thousands of publicly traded companies and exchange-traded funds (ETFs) to choose from, there's a very good chance one or more securities can help you meet your financial goal(s).But among the countless investing strategies on Wall Street, buying and holding high-quality dividend stocks yields an above-average ra ...
Kinder Morgan's Quarterly Earnings Preview: What You Need to Know
Yahoo Finance· 2025-12-26 16:50
Houston, Texas-based Kinder Morgan, Inc. (KMI) operates as an energy infrastructure company. Valued at $60.5 billion by market cap, the company owns and operates pipelines that transport natural gas, gasoline, crude oil, carbon dioxide, and other products, as well as terminals that store petroleum products and chemicals and handle bulk materials like coal and petroleum coke. The midstream giant is expected to announce its fiscal fourth-quarter earnings for 2025 in the near future. Ahead of the event, ana ...
Stryker Earnings Preview: What to Expect
Yahoo Finance· 2025-12-26 16:48
Portage, Michigan-based Stryker Corporation (SYK) is a leading global medical technology company specializing in orthopaedics, MedSurg, and neurotechnology solutions, serving hospitals and healthcare providers worldwide. Valued at $135.7 billion by market cap, the company is best known for its joint-replacement implants, surgical equipment, and advanced technologies, including the Mako robotic-assisted surgery platform, which enhances procedural precision and efficiency. The Medtech giant is expected to ...
Earnings Preview: What to Expect From Sysco’s Report
Yahoo Finance· 2025-12-26 16:45
Valued at $35.6 billion by market cap, Sysco Corporation (SYY) is a leading American multinational food-service distribution company and a core participant in the consumer staples sector. Headquartered in Houston, Texas, Sysco primarily markets and distributes a broad range of food and related products, including fresh, frozen, and prepared foods, meat, seafood, produce, dairy, beverages, and imported specialties, as well as non-food items such as disposable paper products, tableware, kitchen equipment, an ...
Google's Gemini Eating ChatGPT's Lunch: Market Share Gain From 5% To 18% Is 'Clearest Signal' That Alphabet Is Winning AI War - Alphabet (NASDAQ:GOOGL)
Benzinga· 2025-12-26 16:44
生成式AI市场格局重塑 - 谷歌旗下Gemini在生成式AI网络流量份额实现显著跃升 从5.4%增长至18.2% 增幅超过三倍[2] - 行业先驱ChatGPT的市场主导地位大幅下滑 份额从87.2%降至68.0% 下降了19个百分点[3] - 市场分析认为这标志着明确的“接管弧” 行业正从初始炒作阶段进入谷歌基础设施优势显现的阶段[3] 谷歌Gemini增长的核心驱动力 - 增长主要得益于谷歌的“原生分发”优势 Gemini深度集成于Chrome、Android、Workspace和Search等用户高频使用的现有生态中[4] - 这种集成在AI使用从新奇转向日常工具时成为关键差异化因素 能自然“捕获流量” 通过减少切换应用的摩擦来吸引用户[4] - 尽管分发渠道重要 但产品信任更为关键 与微软Copilot份额停滞形成对比 Gemini成功将其广泛触达转化为用户习惯[5][6] 公司股价表现 - Alphabet的C类股股价在2025年表现强劲 年初至今上涨65.59% 过去一年上涨60.16% 远超纳斯达克100指数同期22.31%和17.86%的涨幅[7] - 近期股价在近六个月上涨80.97% 但在近一个月内下跌1.44% 周三收盘价基本持平 微跌0.0032%至每股315.67美元[7]
Starbucks' Q1 2026 Earnings: What to Expect
Yahoo Finance· 2025-12-26 16:42
Seattle, Washington-based Starbucks Corporation (SBUX) is the world’s largest specialty coffee roaster and retailer. With a global footprint of tens of thousands of stores across more than 87 countries, it currently holds a market cap of $96.2 billion. Founded in 1971, Starbucks operates primarily through company-operated and licensed retail stores offering premium coffee, espresso beverages, teas, food items, packaged goods, and merchandise under brands such as Starbucks Coffee, Teavana, Seattle’s Best Co ...
Steel Dynamics' Q4 2025 Earnings: What to Expect
Yahoo Finance· 2025-12-26 16:42
Steel Dynamics, Inc. (STLD), headquartered in Fort Wayne, Indiana, functions as a leading steel producer and metal recycler. Valued at $25.6 billion by market cap, the company’s products include flat rolled steel sheet, engineered bar, special-bar-quality, and structural beams. It also recycles scrap metal and manufactures non-residential building components, including steel joists, girders, trusses, and decks, for construction projects. The leading domestic steel producer and metals recycler is expected t ...
Which states tax Social Security benefits? See the map and tax rates.
Yahoo Finance· 2025-12-26 16:41
Social Security tax rules will change in 2026.Getty Images; Tyler Le/BI Social Security tax rules will change in 2026 at the state and federal level. West Virginia will stop taxing Social Security benefits, leaving seven states that tax benefits. Older Americans will also see expanded federal tax breaks through 2028. Americans on Social Security could see new federal tax breaks in 2026 — and some states will stop taxing benefit income. The largest social safety net in the US provides monthly paym ...
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
BusinessLine· 2025-12-26 16:37
SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity investment from Eli Lilly and Company (”Lilly”).ABL Bio and Lilly are currently conducting joint research and development on multiple therapeutic candidates leveraging the Grabody platform across various mod ...